Paragon Associates & Paragon Associates II Joint Venture’s Allergan plc AGN Stock Holding History

Paragon Associates & Paragon Associates II Joint Venture’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,500	Closed	-$366K	–	35
2019 Q1	$366K	Sell	2,500 -47,500	-95%	-$6.89M	0.35%	26
2018 Q4	$6.68M	Buy	50,000 +10,000	+25%	+$1.64M	8.88%	4
2018 Q3	$7.62M	Hold	40,000	–	–	8.69%	4
2018 Q2	$6.67M	Hold	40,000	–	–	8.67%	4
2018 Q1	$6.73M	Buy	40,000 +30,000	+300%	+$5.03M	9.81%	3
2017 Q4	$1.64M	Buy	+10,000	New	+$1.79M	1.36%	19
2015 Q3	–	Sell	-3,500	Closed	-$1.06M	–	25
2015 Q2	$1.06M	Buy	+3,500	New	+$1.04M	0.92%	16

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's AGN Position: Q2 2019 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,500 shares — an estimated $366K sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in AGN in Q2 2015 and held it in 7 quarters. The position peaked at $7.62M in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Paragon Associates & Paragon Associates II Joint Venture reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Paragon Associates & Paragon Associates II Joint Venture sold 2,500 Allergan plc shares in Q2 2019, an estimated $366K.
Paragon Associates & Paragon Associates II Joint Venture first reported a position in Allergan plc in Q2 2015 and held it in 7 quarters.
Paragon Associates & Paragon Associates II Joint Venture's Allergan plc position peaked at $7.62M in Q3 2018.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q2 2019, filed 14 Aug 2019.